Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A double-blind, randomized, placebo-controlled trial of olanzapine in the prevention of psychotic relapse.
Beasley CM Jr, Sutton VK, Hamilton SH, Walker DJ, Dossenbach M, Taylor CC, Alaka KJ, Bykowski D, Tollefson GD; Olanzapine Relapse Prevention Study Group. Beasley CM Jr, et al. Among authors: dossenbach m. J Clin Psychopharmacol. 2003 Dec;23(6):582-94. doi: 10.1097/01.jcp.0000095348.32154.ec. J Clin Psychopharmacol. 2003. PMID: 14624189 Clinical Trial.
A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia.
Breier A, Meehan K, Birkett M, David S, Ferchland I, Sutton V, Taylor CC, Palmer R, Dossenbach M, Kiesler G, Brook S, Wright P. Breier A, et al. Among authors: dossenbach m. Arch Gen Psychiatry. 2002 May;59(5):441-8. doi: 10.1001/archpsyc.59.5.441. Arch Gen Psychiatry. 2002. PMID: 11982448 Clinical Trial.
A current review of olanzapine's safety in the geriatric patient: from pre-clinical pharmacology to clinical data.
Kennedy JS, Bymaster FP, Schuh L, Calligaro DO, Nomikos G, Felder CC, Bernauer M, Kinon BJ, Baker RW, Hay D, Roth HJ, Dossenbach M, Kaiser C, Beasley CM, Holcombe JH, Effron MB, Breier A. Kennedy JS, et al. Among authors: dossenbach m. Int J Geriatr Psychiatry. 2001 Dec;16 Suppl 1:S33-61. doi: 10.1002/1099-1166(200112)16:1+<::aid-gps571>3.0.co;2-5. Int J Geriatr Psychiatry. 2001. PMID: 11748788 Review.
Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial.
Tohen M, Greil W, Calabrese JR, Sachs GS, Yatham LN, Oerlinghausen BM, Koukopoulos A, Cassano GB, Grunze H, Licht RW, Dell'Osso L, Evans AR, Risser R, Baker RW, Crane H, Dossenbach MR, Bowden CL. Tohen M, et al. Among authors: dossenbach mr. Am J Psychiatry. 2005 Jul;162(7):1281-90. doi: 10.1176/appi.ajp.162.7.1281. Am J Psychiatry. 2005. PMID: 15994710 Clinical Trial.
Response and relapse in patients with schizophrenia treated with olanzapine, risperidone, quetiapine, or haloperidol: 12-month follow-up of the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study.
Dossenbach M, Arango-Dávila C, Silva Ibarra H, Landa E, Aguilar J, Caro O, Leadbetter J, Assunção S. Dossenbach M, et al. J Clin Psychiatry. 2005 Aug;66(8):1021-30. doi: 10.4088/jcp.v66n0810. J Clin Psychiatry. 2005. PMID: 16086618 Clinical Trial.
47 results